Positive correlation of Covid-19 vaccine data in adults with 12-16 year olds may be sufficient for EUA

Covid-19 vaccine virus-1280
Starting the trials in younger vaccine receivers setting is logical as there is positive protection data in adults. Credit: Gerd Altmann from Pixabay